Cargando…

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)

Vaccine-induced immune thrombotic thrombocytopenia (VITT; synonym, thrombosis with thrombocytopenia syndrome, is associated with high-titer immunoglobulin G antibodies directed against platelet factor 4 (PF4). These antibodies activate platelets via platelet FcγIIa receptors, with platelet activatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greinacher, Andreas, Schönborn, Linda, Siegerist, Florian, Steil, Leif, Palankar, Raghavendra, Handtke, Stefan, Reder, Alexander, Thiele, Thomas, Aurich, Konstanze, Methling, Karen, Lalk, Michael, Völker, Uwe, Endlich, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863951/ https://www.ncbi.nlm.nih.gov/pubmed/35512907 http://dx.doi.org/10.1053/j.seminhematol.2022.02.004

Ejemplares similares

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
por: Greinacher, Andreas, et al.
Publicado: (2021)

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination
por: Handtke, Stefan, et al.
Publicado: (2021)

The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies
por: Vayne, Caroline, et al.
Publicado: (2022)

Longitudinal Aspects of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

Decline in Pathogenic Antibodies over Time in VITT
por: Schönborn, Linda, et al.
Publicado: (2021)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) after SARS‐CoV‐2 vaccination: Two cases from Germany with unusual presentation
por: Edmonds, Rhea, et al.
Publicado: (2023)

The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potential New Treatment for Vιττ
por: Vayne, Caroline, et al.
Publicado: (2021)

Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines
por: Michalik, Stephan, et al.
Publicado: (2022)

Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)—Insights from Clinical Cases, In Vitro Studies and Murine Models
por: Dabbiru, Venkata A. S., et al.
Publicado: (2023)

Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)

Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
por: Dix, Caroline, et al.
Publicado: (2022)

SARS-CoV-2 Infection in Patients with a History of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
por: Greinacher, Andreas, et al.
Publicado: (2022)

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)

Toward the Relevance of Platelet Subpopulations for Transfusion Medicine
por: Handtke, Stefan, et al.
Publicado: (2018)

Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway
por: Salih, Farid, et al.
Publicado: (2022)

Vaccination-induced thrombocytopenia and thrombosis (VITT) and pre-VITT: Do not miss (or misdiagnose) the new member of the thrombotic thrombocytopenias family
por: Noyé, Mickaël, et al.
Publicado: (2022)

Divalent magnesium restores cytoskeletal storage lesions in cold-stored platelet concentrates
por: Aurich, Konstanze, et al.
Publicado: (2022)

Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
por: John, Christy V., et al.
Publicado: (2022)

Role of Anticoagulation and IVIG in Treatment of Vaccine-Induced Thrombotic Thrombocytopenia (VITT)
por: Tariq, Anosha, et al.
Publicado: (2022)

Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
por: Schönborn, Linda, et al.
Publicado: (2022)

Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
por: Kanack, Adam J., et al.
Publicado: (2022)

Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021)

Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT)
por: Cliff-Patel, Nikita, et al.
Publicado: (2021)

A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis
por: Mendes-de-Almeida, Daniela P., et al.
Publicado: (2023)

Audit of pathology requesting behaviour in the setting of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Maclean, Marsali, et al.
Publicado: (2022)

Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
por: Graf, Tilmann, et al.
Publicado: (2021)

Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report
por: Günther, Albrecht, et al.
Publicado: (2021)

Microsurgical complication associated with vaccine-induced immune thrombotic thrombocytopenia (VITT): A case report
por: Hung, Chen-Ting, et al.
Publicado: (2023)

COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes
por: Allas, Gewil Daniella Olipas, et al.
Publicado: (2022)

Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
por: Thiele, Thomas, et al.
Publicado: (2021)

AZD-1222: Vaccine-induced thrombosis with thrombocytopenia (VITT) and arterial and venous thrombotic stroke : case report
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023)

Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations
por: Lavin, Michelle, et al.
Publicado: (2021)

Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report
por: Mancuso, Michelangelo, et al.
Publicado: (2022)

Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection
por: McGonagle, Dennis, et al.
Publicado: (2021)

Letter to editor – observation on the article titled “Vaccine-Induced Thrombotic Thrombocytopenia (VITT): first report from India”
por: Kotwal, Jyoti, et al.
Publicado: (2023)

COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and Cerebral Venous Sinus Thrombosis (CVST)- Lessons for India
por: Khan, Erum, et al.
Publicado: (2022)

Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
por: John, Christy V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2lsl1cu23vhoetrq2c0gg76dhk